Javascript must be enabled to continue!
The Use of an Adenine Diet to Induce Uremic Cardiac Hypertrophy in Mice
View through CrossRef
Over 90% of patients with chronic kidney disease (CKD) will develop cardiac hypertrophy and approximately half of them will die from cardiovascular disease. Recently, our lab and others have shown that uremic toxins like fibroblast growth factor 23 can directly induce pathological cardiac hypertrophy. While the understanding of the mechanisms responsible for cardiac hypertrophy in uremia is improving, there is a strong need to establish a simple, non‐surgical, and reproducible mouse model of uremic cardiac hypertrophy. An adenine diet has been shown to cause nephropathy and uremia; however, the link between ingestion of adenine and uremic cardiac hypertrophy has not been established. The objective of the present study was to develop a mouse model of dietary adenine‐induced uremia that results in cardiac hypertrophy. Thirty CD1 mice were randomly divided into two groups and fed for 12 weeks: 1) a control group (CON, n=15) fed standard feed, and 2) an adenine (0.2–0.15%) diet intervention group (AD, n=15). The percentage of adenine was adjusted weekly based on temporal assessments of blood urea nitrogen (BUN) to ensure initiation and maintenance of renal injury. Throughout the protocol, the BUN in AD mice was significantly elevated (~80 mg/dl) compared to that of the controls (~30 mg/dl). Post‐intervention, serum levels of BUN (+118%), creatinine (+72%), and phosphate (+107%) were significantly higher in the AD mice. Kidney mass/body mass ratio was significantly lower (−38%) in AD mice, suggesting renal atrophy. The AD mice also had increased heart mass/body mass ratio (+25%) and increased ventricular wall thickness, consistent with hypertrophy. Our data suggests that over 12 weeks, the induction of uremia in the AD group resulted in cardiac hypertrophy. Adenine diet fed mice may be a suitable model to study novel therapeutic treatments to prevent or treat the development of cardiac hypertrophy during uremia.
Support or Funding Information
University of Memphis Faculty Research Grant to CDT; Honors Summer Research Fellowship, University of Memphis Helen Hardin Honors Program to EMA
Title: The Use of an Adenine Diet to Induce Uremic Cardiac Hypertrophy in Mice
Description:
Over 90% of patients with chronic kidney disease (CKD) will develop cardiac hypertrophy and approximately half of them will die from cardiovascular disease.
Recently, our lab and others have shown that uremic toxins like fibroblast growth factor 23 can directly induce pathological cardiac hypertrophy.
While the understanding of the mechanisms responsible for cardiac hypertrophy in uremia is improving, there is a strong need to establish a simple, non‐surgical, and reproducible mouse model of uremic cardiac hypertrophy.
An adenine diet has been shown to cause nephropathy and uremia; however, the link between ingestion of adenine and uremic cardiac hypertrophy has not been established.
The objective of the present study was to develop a mouse model of dietary adenine‐induced uremia that results in cardiac hypertrophy.
Thirty CD1 mice were randomly divided into two groups and fed for 12 weeks: 1) a control group (CON, n=15) fed standard feed, and 2) an adenine (0.
2–0.
15%) diet intervention group (AD, n=15).
The percentage of adenine was adjusted weekly based on temporal assessments of blood urea nitrogen (BUN) to ensure initiation and maintenance of renal injury.
Throughout the protocol, the BUN in AD mice was significantly elevated (~80 mg/dl) compared to that of the controls (~30 mg/dl).
Post‐intervention, serum levels of BUN (+118%), creatinine (+72%), and phosphate (+107%) were significantly higher in the AD mice.
Kidney mass/body mass ratio was significantly lower (−38%) in AD mice, suggesting renal atrophy.
The AD mice also had increased heart mass/body mass ratio (+25%) and increased ventricular wall thickness, consistent with hypertrophy.
Our data suggests that over 12 weeks, the induction of uremia in the AD group resulted in cardiac hypertrophy.
Adenine diet fed mice may be a suitable model to study novel therapeutic treatments to prevent or treat the development of cardiac hypertrophy during uremia.
Support or Funding Information
University of Memphis Faculty Research Grant to CDT; Honors Summer Research Fellowship, University of Memphis Helen Hardin Honors Program to EMA.
Related Results
Mediator kinase submodule-dependent regulation of cardiac transcription
Mediator kinase submodule-dependent regulation of cardiac transcription
<p>Pathological cardiac remodeling results from myocardial stresses including pressure and volume overload, neurohumoral activation, myocardial infarction, and hypothyroidism...
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
GW24-e2259 Evaluation of atherosclerosis in low density lipoprotein receptor defect mice by ultrasound biomicroscopy
GW24-e2259 Evaluation of atherosclerosis in low density lipoprotein receptor defect mice by ultrasound biomicroscopy
Objectives
Low density lipoprotein receptor defect mice model by transgenetic technology was used to detect atherosclerosis by Ultrasound Biology (UBM). And evalu...
Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma.
Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma.
Uremia is associated with bleeding diathesis. Platelet adhesion to the subendothelium is inhibited by a factor in uremic plasma that may play a role in the disturbed hemostasis of ...
Cardiac effects of acute hyperinsulinemia and chronic fat feeding
Cardiac effects of acute hyperinsulinemia and chronic fat feeding
<p>Diabetic cardiomyopathy characterized by left ventricular hypertrophy predisposes diabetic and obese individuals to development of cardiac dysfunction and subsequently to ...
Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway
Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway
Histone deacetylase (HDAC) expression and enzymatic activity are dysregulated in cardiovascular diseases. Among Class I HDACs, HDAC2 has been reported to play a key role in cardiac...
Cardiac-specific deletion of myosin phosphatase targeting subunit 2 alleviates cardiac fibrosis in mineralocorticoid receptor-related hypertension
Cardiac-specific deletion of myosin phosphatase targeting subunit 2 alleviates cardiac fibrosis in mineralocorticoid receptor-related hypertension
Abstract
Introduction
Myosin phosphatase targeting subunit 2 (MYPT2) is a crucial subunit of cardiac myosin light chain (MLC) ph...
Unraveling the Mechanism Behind the Ketogenic Diet-Mediated Reversal of Heart Failure in Mice
Unraveling the Mechanism Behind the Ketogenic Diet-Mediated Reversal of Heart Failure in Mice
It has become clear that heart failure involves a host of metabolic alterations, and nutritional or pharmacologic modulation of cardiac metabolism can improve heart failure. We pre...

